Medicine guide

SYNAGIS

As listed in the register: SYNAGIS 50 mg/0,5 ml, solution injectable

50 mg · solution injectable

  • Prescription only
Active substance
Palivizumab
Made by
ASTRAZENECA AB

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byASTRAZENECA AB
Active substancePalivizumab
Strength50 mg
Formsolution injectable
Routeintramusculaire
Dispensing (as stated by the register)liste I
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/99/117
Name in the registerSYNAGIS 50 mg/0,5 ml, solution injectable
Packs1 flacon(s) en verre de 0,5 ml
CIS68932534
CIP133400930072318

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • solution injectable2 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.